A hospital on Long Island is testing a vaccine against breast cancer and is accepting patients for a clinical trial.

Stony Brook Cancer Center is one of 160 sites worldwide participating in the FLAMINGO-01 Phase III clinical trial.

Intraoperative reirradiation in combination with a second breast-conserving surgery is safe and well tolerated in patients ...

While the method may sound unfamiliar, it has been clinically validated for decades and remains central to preventing ...

Researchers at NYU Langone Health and its Perlmutter Cancer Center have revealed that blood tests could predict the return of skin cancer. Melanoma is a less common form of skin cancer that is more ...

Nearly two-thirds of survivors are at least somewhat worried about disease recurrence, researchers reported at AACR 2026.

“Aspirin is a drug that is readily available globally and extremely inexpensive compared to many modern cancer drugs, which ...

Recent advances in healthcare research have increasingly leveraged routinely collected administrative data to monitor cancer recurrence. This approach circumvents the delays and resource-intensive ...

A recent study examines the association between COVID-19 infection and an increased risk of recurrence in breast cancer ...

Worries have persisted that cancer survivors in remission might face increased recurrence risk when treated with biologic drugs for autoimmune disease. This Danish study of rheumatoid arthritis ...

The community is coming together this weekend to support 19-year-old Hannah Marcum as she battles a rare form of ovarian ...